Platelet Function Testing vs Standard Care What Clinical Data Really Shows Introduction High on treatment platelet reactivity remains a significant clinical challenge in patients receiving clopidogrel, with approximately one in three treated individuals demonstrating inadequate platelet inhibition. This variability in response has important therapeutic
Author: Nancy Ogbonna
Targeting α-Synuclein: The Next Frontier in Parkinson’s Therapy
Targeting α-Synuclein The Next Frontier in Parkinson’s Therapy Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting an estimated 10 million individuals worldwide. Its prevalence is expected to rise substantially with population aging, creating an expanding clinical and socioeconomic
Thyroid Cancer Overdiagnosis: When Screening Causes More Harm Than Good
Thyroid Cancer Overdiagnosis When Screening Causes More Harm Than Good Abstract The incidence of thyroid cancer has risen substantially over the past three decades, drawing increased attention from clinicians, researchers, and public health authorities. Much of this rise has been attributed not to a true surge in aggressive
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a transformative class of medications in the management of type 2 diabetes, demonstrating an approximate 14 percent reduction in major adverse cardiovascular events. Initially developed
Medical Alert Watch Technology: From Detection to Emergency Response in Minutes
Why Biomarker-Driven Treatment Fails: The Hidden Role of Histology
Why Biomarker-Driven Treatment Fails The Hidden Role of Histology Introduction Biomarker-driven treatment has fundamentally transformed oncology, ushering in an era of precision medicine in which therapeutic decisions are increasingly guided by the molecular characteristics of tumors rather than their anatomical origin alone. A
Targeting the Bone Marrow Microenvironment in Myeloma and Acute Myeloid Leukemia: Novel Therapeutic Approaches and Clinical Implications
Targeting the Bone Marrow Microenvironment in Myeloma and Acute Myeloid Leukemia Novel Therapeutic Approaches and Clinical Implications Abstract The bone marrow microenvironment is increasingly recognized as a central determinant in the initiation, progression, and therapeutic resistance of hematologic malignancies, particularly multiple myeloma and acute myeloid leukemia
Prediabetes Management in Family Practice: Comparative Effectiveness of Lifestyle Intervention, Metformin, and Anti-Obesity Pharmacotherapy
Prediabetes Management in Family Practice Comparative Effectiveness of Lifestyle Intervention, Metformin, and Anti-Obesity Pharmacotherapy Abstract Prediabetes represents a critical window for intervention in the trajectory toward type 2 diabetes mellitus, offering family physicians an opportunity to prevent or significantly delay disease onset. With global
Postoperative Delirium and Brain Health: Can the Anesthesiologist Prevent Dementia?
Postoperative Delirium and Brain Health Can the Anesthesiologist Prevent Dementia Abstract Postoperative delirium has emerged as a major concern in perioperative medicine, particularly among older adults undergoing surgical procedures. Characterized by an acute and fluctuating disturbance in attention, awareness, and cognition, postoperative delirium affects
CRISPR and Gene Editing in Neurodegenerative Diseases: Current Applications and Future Therapeutic Potential
CRISPR and Gene Editing in Neurodegenerative Diseases Current Applications and Future Therapeutic Potential Abstract Neurodegenerative diseases continue to pose profound challenges to modern medicine, affecting millions of individuals worldwide and contributing significantly to disability, mortality, and healthcare expenditure. Disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease,
